Precipio Gets Extension to Meet Nasdaq Listing Requirement

May

Identifying Molecular Drivers of Cancer via Comprehensive Sequencing of a Large Cohort with Matched Germline and Clinical Data

M2Gen’s Oncology Research Information Exchange Network (ORIEN) Avatar Research Program collects and studies consented cancer patients’ biospecimens and companion clinical information for the development of improved oncology treatments.

Jun

Featured Webinar

The Need for Digital Spatial Profiling for Host-Pathogen Interaction: A York Perspective

Core facilities support a broad range of scientific studies and must constantly integrate new technologies and analysis to underpin their users’ research. Areas for development include higher multiplex capabilities, greater quantification, correlation to other tools, as well as multi-omics.

Jun

Featured Webinar

COVID-19 Testing, Treatment and Future Outlook

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.

Menu

Precipio Gets Extension to Meet Nasdaq Listing Requirement

To read the full story....

Breaking News

NantOmics Shuts Down Genos Direct-to-Consumer Genomics Services

Colorectal Cancer Study Reveals Tumor Mutation, Immune Microenvironment Relationships

French Genetic Study Provides Insights Into Pre-Agriculture to Iron Age Populations

Takeda's Alunbrig Gets First-Line FDA Approval With Abbott CDx in ALK-Positive Lung Cancer

Top Five Articles on GenomeWeb Last Week: Roche, COVID-19, Clinico-Genomic Lung Cancer Study, and More

Genetic Technologies Prices $8M Public Offering

Recent Headlines from
Precision Oncology News

Opdivo, Yervoy Another First-Line Option in NSCLC, Though Maybe Not Some Oncologists' Top Choice

Janssen Antibody Produces Durable Responses in Lung Cancer Subset With Poor Prognosis

NHGRI-Funded KidsCanSeq Study Brings Clinical Sequencing to Texas Hospitals

NICE, NHS England's Pandemic Guideline Gives Temporary Access to Precision Oncology Treatments

Indivumed Global Alliance to Broaden Access to Multi-Omics Algorithms, Precision Medicine Education

Featured White Papers

Identifying Molecular Drivers of Cancer via Comprehensive Sequencing of a Large Cohort with Matched Germline and Clinical Data

The Need for Digital Spatial Profiling for Host-Pathogen Interaction: A York Perspective

COVID-19 Testing, Treatment and Future Outlook

What's Popular?

NeoGenomics, Inivata Partner to Commercialize Lung Cancer Liquid Biopsy Test

AstraZeneca, ArcherDx Partner on Minimal Residual Disease Monitoring for Lung Cancer Drug Trials

Colorectal Cancer Study Reveals Tumor Mutation, Immune Microenvironment Relationships

Takeda's Alunbrig Gets First-Line FDA Approval With Abbott CDx in ALK-Positive Lung Cancer

Bio-Techne, Leica Biosystems Receive CE Mark for Pathology Detection Kit, Platform

Sponsorships